
Dr Gemma Knight
Clinical Psychologist/Therapist in Psychedelics
Contact details
Biography
Gemma Knight first started at King’s in 2010 when she completed her MSc in Mental Health Studies, going on to hold a Research Assistant post until 2013. She completed her clinical training and qualified as a Clinical Psychologist (ClinPsyD) from the University of Manchester in 2016. She now works part time in Older Adult services in in South London and Maudsley NHS Foundation Trust as part of the Croydon Care Home Intervention Team, supporting care home staff to better understand and support people living with dementia. She returned to King’s in January 2019 to join the Psychedelic Trials Group in the Centre for Affective Disorders, working as a lead therapist on clinical trials investigating use of psilocybin (magic mushrooms) for treatment-resistant depression.
Research Interests
- Use of psychedelics in mental health
- End of life care
- Acceptance and Commitment Therapy (ACT)
Research Groups
Psychedelic Trials Group
Research

Psychoactive Trials Group
Psychedelic Trials Group at the IoPPN
News
Largest trial to date shows that psilocybin reduces depression symptoms
A new multicentre clinical trial led by COMPASS Pathways across 22 international sites, including the Institute of Psychiatry, Psychology & Neuroscience...

Research

Psychoactive Trials Group
Psychedelic Trials Group at the IoPPN
News
Largest trial to date shows that psilocybin reduces depression symptoms
A new multicentre clinical trial led by COMPASS Pathways across 22 international sites, including the Institute of Psychiatry, Psychology & Neuroscience...
